AFP and hepatocellular carcinoma: In the clinical application of HCC, traditional diagnostic methods such as serum alpha-fetoprotein (AFP) has limited specificity and sensitivity, current data show that there is no single biomarker used for the detection of HCC alone, especially in the early stages of development (21).